SRC
CVET

Shufro Rose & Co’s Covetrus, Inc. Common Stock CVET Stock Holding History

Shufro Rose & Co’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12,100
Closed -$251K – 346
2022
Q2 		$251K Hold
12,100
– – 0.02% 244
2022
Q1 		$203K Hold
12,100
– – 0.02% 285
2021
Q4 		$242K Hold
12,100
– – 0.02% 256
2021
Q3 		$219K Hold
12,100
– – 0.02% 258
2021
Q2 		$327K Hold
12,100
– – 0.02% 212
2021
Q1 		$363K Hold
12,100
– – 0.03% 200
2020
Q4 		$348K Sell
12,100
-15,160
-56% -$409K 0.03% 196
2020
Q3 		$665K Sell
27,260
-2,240
-8% -$48.3K 0.06% 129
2020
Q2 		$528K Hold
29,500
– – 0.05% 146
2020
Q1 		$240K Buy
29,500
+12,760
+76% +$146K 0.03% 223
2019
Q4 		$221K Sell
16,740
-20,850
-55% -$252K 0.02% 269
2019
Q3 		$447K Buy
37,590
+17,200
+84% +$318K 0.04% 166
2019
Q2 		$499K Buy
+20,390
New +$587K 0.05% 161

Other funds holding CVET

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Shufro Rose & Co's CVET Position: Q3 2022 in Review

Shufro Rose & Co sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2022, closing a stake of 12,100 shares — an estimated $251K sold.

Shufro Rose & Co first reported a position in CVET in Q2 2019 and held it in 13 quarters. The position peaked at $665K in Q3 2020. 250 funds tracked by Wall St. Rank hold CVET as of Q3 2022.

  • Shufro Rose & Co reported no remaining Covetrus, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Shufro Rose & Co sold 12,100 Covetrus, Inc. Common Stock shares in Q3 2022, an estimated $251K.
  • Shufro Rose & Co first reported a position in Covetrus, Inc. Common Stock in Q2 2019 and held it in 13 quarters.
  • Shufro Rose & Co's Covetrus, Inc. Common Stock position peaked at $665K in Q3 2020.
  • 250 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2022.

Based on Shufro Rose & Co's 13F filing for Q3 2022, filed 24 Oct 2022.